Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1934 of 6351
-
Can virtual care keep COPD patients out of the ER?
Disease control CompletedThis type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods. The investigators wi…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New surgery targets hidden cancer in ovarian patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and the effectiveness of hepato-celiac lymphadenectomy in the treatment of primarily diagnosed advanced epithelial ovarian cancer and platinum-sensitive recurrent ovarian cancer.
Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug cocktail aims to shrink advanced stomach tumors
Disease control OngoingThis early phase I trial studies the effect of pembrolizumab and lenvatinib in treating patients with gastroesophageal adenocarcinoma that has spread to other places in the body (advanced/metastatic) or cannot be removed by surgery (unresectable). Immunotherapy with monoclonal an…
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Chickpea power: a Plant-Based drink that could speed up muscle recovery?
Symptom relief CompletedThis randomized, placebo-controlled crossover study evaluated the safety and potential beneficial effects of a beverage containing chickpea protein hydrolysate in football players. Participants received the chickpea protein hydrolysate beverage and a matched protein-containing pl…
Sponsor: Instituto de la Grasa • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Hidden heart risk: tiny vessel damage may explain some heart attacks
Knowledge-focused Recruiting nowTo compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated by optical coherence tomography (OCT), invasive and non-invasive coronary physiologic assessment.
Sponsor: Chonnam National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New care model aims to save mothers and babies with sickle cell disease
Disease control OngoingTo implement an effective but low-cost strategy to decrease SCD maternal and perinatal mortality in Ghana. The objectives are to 1) assess the impact of a multidisciplinary SCD-obstetric team for decreasing mortality across three hospital sites in Ghana. 2) assess the implementat…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a special stretching technique help older adults with muscle loss stay steady on their feet?
Disease control CompletedSarcopenia is an age-related skeletal muscle disorder characterized by reduced muscle strength, muscle mass, and physical performance. It may lead to impaired balance, reduced mobility, falls, loss of independence, and reduced quality of life. Exercise is a central component of s…
Sponsor: Uşak University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Statins take on COPD: could a heart drug curb lung Flare-Ups?
Disease control OngoingIt is a randomized, multicenter, prospective, double-blind, placebo controlled, interventional clinical trial that will be conducted in Poland, in about 12 Hospital Pulmonary Departments to evaluate the effectiveness of atorvastatin on the reduction of inflammation process in pat…
Phase 4 • Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
MRNA HIV vaccine trial launches in healthy volunteers
Vaccine OngoingThis is an open-label, multicenter, randomized phase 1 study to evaluate the safety and immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV trimer mRNA. These trimers are based on the BG505 MD39 native-like trimer reported in Steichen et al. Immun…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 07:54 UTC
-
Can a 10-Session video therapy tame tantrums in kids with autism?
Symptom relief CompletedThe purpose of this research study is to evaluate a time-limited version of Parent Child Interaction Therapy (PCIT) delivered via telehealth for young children with autism spectrum disorder (ASD) and disruptive behavior problems. Families will be randomly assigned to receive 10 s…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Family dinners get a high-tech makeover to fight childhood obesity
Disease control By invitation onlyThe proposed study is a 12-month, individual randomized controlled trial (RCT). The main aim of the study is to decrease cardiovascular disease risk (BMI percentile, neck circumference) and improve child diet quality in children ages 5-10 years old by increasing family meal quali…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Custom 3D-Printed ankle implant offers new hope for severe bone loss
Disease control Recruiting nowOn February 17th, 2021, the FDA officially approved the use of the first patient-specific 3D-printed talar implant for compassionate use. This is a patient-specific talar spacer designed to completely replace the talus for the treatment of talar avascular necrosis. The implant re…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for picky eaters: study tackles childhood eating disorder
Symptom relief CompletedAvoidant Restrictive Food Intake Disorder (ARFID) is a disorder that affects toddlers, children, adolescents, and adults. Individuals with ARFID are not able to consume an adequate amount or variety of food to a degree that it affects their mental and/or physical health. ARFID of…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Alzheimer's drug vs. brain exercises: which works better?
Symptom relief Recruiting nowDonepezil, as well as the other symptomatic drugs of Alzheimer's disease, is not any more reimbursed by the French healthcare system, due to a controversy about its efficiency. French health authorities currently preconize a non-rug approach based on cognitive remediation or stim…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Diet showdown: could paleo or keto diets ease MS symptoms?
Symptom relief OngoingThe overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of…
Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated Jun 26, 2026 16:05 UTC
-
Can botox shots warm up cold fingers? a trial investigates
Symptom relief CompletedRaynaud's Phenomenon (RP) is the most common vasospastic disorder encountered by hand surgeons with an estimated prevalence of 5% in the general population. It's manifestations are broad, and can range from minor to severe. Sometimes it can be refractory to treatments. The goal o…
Phase 4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Texting your way to quit smoking: a WeChat coach takes on the habit
Disease control CompletedThe study team will develop and assess the feasibility and acceptability of a WeChat-based peer-group mobile messaging smoking cessation intervention targeting Chinese immigrant smokers in New York City (NYC). For Aim 1, the study team will develop a message library for the WeCha…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New 'Four-in-One' antibody takes on Hard-to-Treat blood cancers
Disease control OngoingIn this study, the safety, tolerability and preliminary effectiveness of GNC-035 in patients with relapsed/refractory hematologic malignancies will be investigated to assess the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for MTD …
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Brain zapping with light: a new hope for attention problems?
Symptom relief Recruiting nowInattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical hypometabolism has been hypothesized to contribute to inattentiveness in ADHD. Transcranial photobiomodulat…
Sponsor: Francisco Gonzalez-Lima, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New combo tackles brain tumors in melanoma and kidney cancer patients
Disease control Stopped earlyThis is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma and 2) renal cell carcinoma (RCC).
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC